Xencor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
XNCR Key Statistics
Stock Snapshot
Xencor(XNCR) stock is priced at $13.55, giving the company a market capitalization of 967.61M. It carries a P/E multiple of -6.75.
As of 2026-02-26, Xencor(XNCR) stock has fluctuated between $12.00 and $14.54. The current price stands at $13.55, placing the stock +12.9% above today's low and -6.8% off the high.
The Xencor(XNCR)'s current trading volume is 1.49M, compared to an average daily volume of 512.24K.
During the past year, Xencor(XNCR) stock moved between $6.92 at its lowest and $18.69 at its peak.
During the past year, Xencor(XNCR) stock moved between $6.92 at its lowest and $18.69 at its peak.
XNCR News
Barclays raised the firm’s price target on Xencor (XNCR) to $27 from $26 and keeps an Overweight rating on the shares. The firm updated the company’s model post...
Reports Q4 revenue $28.2M, consensus $30M. “Xencor’s (XNCR) lead oncology drug candidate is XmAb819, a novel first-in-class T-cell engager that could offer a mu...
Analyst ratings
92%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.